Grufity logoGrufity logo

CME Group Inc Stock Research

CME

187.21USD+4.54(+2.49%)Delayed

Market Summary

USD187.21+4.54
Delayed
2.49%

CME Stock Price

CME RSI Chart

CME Valuation

Market Cap

67.2B

Price/Earnings (Trailing)

24.96

Price/Sales (Trailing)

13.38

EV/EBITDA

16.87

Price/Free Cashflow

22.64

CME Price/Sales (Trailing)

CME Profitability

EBT Margin

70.74%

Return on Equity

10.01%

Return on Assets

1.54%

Free Cashflow Yield

4.42%

CME Fundamentals

CME Revenue

Revenue (TTM)

5.0B

Revenue Y/Y

5.27%

Revenue Q/Q

-1.63%

CME Earnings

Earnings (TTM)

2.7B

Earnings Y/Y

2.03%

Earnings Q/Q

-6.14%

Price Action

52 Week Range

166.55250.73
(Low)(High)

Last 7 days

1.0%

Last 30 days

-1.4%

Last 90 days

5.9%

Trailing 12 Months

-20.9%

CME Financial Health

Current Ratio

1.01

CME Investor Care

Dividend Yield

4.54%

Dividend/Share (TTM)

8.5

Shares Dilution (1Y)

0.10%

Diluted EPS (TTM)

7.4

Peers (Alternatives to CME Group)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
67.2B
5.0B
-1.37% -20.87%
24.96
13.38
7.03% 2.07%
55.5B
9.6B
-10.69% -24.62%
38.36
5.76
5.10% -64.37%
26.1B
6.2B
-12.89% -69.27%
23.21
4.19
5.78% -5.22%
24.5B
6.5B
-12.11% -22.62%
12.06
3.54
-15.43% -49.47%
13.1B
4.0B
-4.92% 7.40%
55.9
3.32
13.27% -55.58%
MID-CAP
7.9B
2.7B
-12.10% 23.15%
4.31
2.95
95.77% 12.59%
7.5B
2.0B
-12.37% -3.86%
15.68
3.75
3.79% -13.01%
6.2B
4.6B
-17.08% -14.81%
9.36
1.35
-3.98% -19.72%
1.9B
64.7B
-11.71% 27.62%
8
0.03
35.87% 74.73%
SMALL-CAP
2.0B
1.8B
17.91% 16.69%
41.14
1.12
16.43% -60.72%
1.8B
2.4B
-12.59% -48.39%
6.93
0.78
-15.89% -44.42%
1.1B
1.5B
0.39% 32.10%
14.3
0.71
-27.22% -74.14%
816.3M
10.3M
-0.68% -10.61%
-15.36
79.32
-29.47% -152.67%
742.8M
301.3M
9.41% -21.41%
14.66
2.47
-0.98% 1.78%
445.7M
1.1B
-15.80% -8.69%
13.78
0.4
-20.31% -79.65%

Financials for CME Group

Income Statement (Last 12 Months)
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Revenue1.2%5,0194,9594,8414,7834,690
Costs and Expenses1.2%2,0041,9801,9872,0042,045
EBITDA-4.0%3,8193,9783,9283,714-
EBITDA Margin-7.4%0.76*0.82*0.82*0.79*-
Earnings Before Taxes-7.5%3,5513,8393,651--
EBT Margin-1.2%0.71*0.72*0.79*0.76*0.73*
Interest Expenses-0.1%133133---
Net Income0.5%2,6912,6782,9252,7732,636
Net Income Margin-0.7%0.54*0.54*0.60*0.58*0.56*
Free Cahsflow11.9%2,9662,6502,6162,4772,275
Balance Sheet
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Assets-2.4%174,176178,432176,671205,918196,780
  Current Assets-2.9%139,078143,253141,451171,004161,762
    Cash Equivalents27.7%2,7202,1301,8802,0462,835
  Net PPE-2.1%456466482494505
  Goodwill0.3%10,48310,44710,48410,51610,528
Liabilities-1.9%147,297150,181148,670178,181169,381
  Current Liabilities-2.1%137,688140,573139,000168,459160,398
.    Short Term Borrowings10.3%16.0015.00--749
Shareholder's Equity-4.9%26,87928,25128,00227,73727,399
  Retained Earnings-22.3%4,7476,1125,7985,4995,152
  Additional Paid-In Capital0.1%22,26222,23522,23222,20622,190
Accumulated Depreciation1.2%1,1111,0971,0711,039-
Shares Outstanding0.0%359359359--
Minority Interest------
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Cashflow From Operations11.4%3,0562,7432,7172,5992,402
  Share Based Compensation8.9%84.0077.0074.0074.0075.00
Cashflow From Investing-23.5%-489-396-31470.0058.00
Cashflow From Financing-133.0%-25,381-10,895-4,50642,73169,909
  Dividend Payments1.4%2,6342,5972,5562,5152,189

Risks for CME

What is the probability of a big loss on CME?

41.1%


Probability that CME Group stock will be more than 20% underwater in next one year

9.2%


Probability that CME Group stock will be more than 30% underwater in next one year.

0%


Probability that CME Group stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does CME drawdown profile look like?

Y-axis is the maximum loss one would have experienced if CME Group was unfortunately bought at previous high price.

Drawdowns

Returns for CME

Cumulative Returns on CME

15.4%


10-Year Cumulative Returns

13.0%


7-Year Cumulative Returns

4.6%


5-Year Cumulative Returns

2.5%


3-Year Cumulative Returns

What are the long-term rolling returns for CME?

FIve years rolling returns for CME Group.

Annualized Returns

Which funds bought or sold CME recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-03-15
B. Riley Wealth Advisors, Inc.
reduced
-32.91
-279,598
524,402
0.01%
2023-03-10
VICTORY CAPITAL MANAGEMENT INC
reduced
-4.88
-5,740,660
53,451,300
0.06%
2023-03-06
NORTH STAR ASSET MANAGEMENT INC
reduced
-1.51
-75,915
1,098,080
0.07%
2023-03-06
Rockefeller Capital Management L.P.
reduced
-22.32
-6,880,000
19,324,000
0.10%
2023-03-03
TIAA, FSB
reduced
-1.12
-46,488
714,512
-%
2023-03-02
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA
new
-
58,856
58,856
-%
2023-03-01
Lakewood Asset Management LLC
new
-
40,000
40,000
0.03%
2023-03-01
Regal Investment Advisors LLC
added
27.61
73,755
419,755
0.04%
2023-02-28
Voya Investment Management LLC
reduced
-2.11
-13,984,400
183,989,000
0.26%
2023-02-27
Cravens & Co Advisors, LLC
new
-
614,625
614,625
0.57%

1–10 of 45

Latest Funds Activity

Are funds buying CME calls or puts?
Calls
Puts
Are funds bullish or bearish(Calls - Puts)?
Net Call Options
No. of funds that own CME
No. of Funds

CME Group News

Best Stocks

Brookstone Capital Management Buys a Share of CME Group Inc ....

Best Stocks,
9 minutes ago

brownfieldagnews.com

Baystreet.ca

Baystreet.ca

Stocks Gain to Begin Week.

Baystreet.ca,
5 hours ago

Danbury News Times

Investopedia

Baystreet.ca

Schedule 13G FIlings of CME Group

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2023
capital world investors
4.4%
15,768,261
SC 13G/A
Feb 09, 2023
vanguard group inc
9.21%
33,139,178
SC 13G/A
Jan 31, 2023
blackrock inc.
7.2%
26,025,197
SC 13G/A
Feb 11, 2022
capital world investors
9.3%
33,473,618
SC 13G/A
Feb 09, 2022
vanguard group inc
8.72%
31,356,965
SC 13G/A
Feb 03, 2022
blackrock inc.
6.7%
24,162,418
SC 13G/A
Feb 16, 2021
capital world investors
9.5%
33,945,618
SC 13G/A
Feb 10, 2021
vanguard group inc
7.86%
28,231,615
SC 13G/A
Jan 29, 2021
blackrock inc.
7.0%
25,295,042
SC 13G/A
Feb 14, 2020
capital world investors
10.0%
35,842,471
SC 13G/A

CME Fair Value

CME Group fair value in different scenarios

The table shows the Fair Value estimates for CME Group for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.
Fair ValueVery PessimisticPessimisticBase CaseOptimisticVery Optimistic
Very Low Inflation

-

-

-

-

-

-

-

-

-

-
Current Inflation

61.39

-67.21%

85.56

-54.30%

111.66

-40.36%

155.16

-17.12%

208.82

11.54%
Very High Inflation

-

-

-

-

-

-

-

-

-

-

Historical CME Group Fair Value Estimates


Very Pessimistic Case
Pessimistic Case
Fair Value
Optimistic Case
Very Optimistic Case
Closing Stock Price

Recent SEC filings of CME Group

View All Filings
Date Filed Form Type Document
Mar 16, 2023
DEF 14A
DEF 14A
Mar 16, 2023
DEFA14A
DEFA14A
Mar 10, 2023
8-K
Current Report
Feb 28, 2023
8-K
Current Report
Feb 27, 2023
10-K
Annual Report
Feb 16, 2023
4
Insider Trading
Feb 13, 2023
SC 13G/A
Major Ownership Report
Feb 09, 2023
SC 13G/A
Major Ownership Report
Feb 08, 2023
8-K
Current Report
Feb 07, 2023
5
Insider Trading

Latest Insider Trading transactions for CME

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-02-16
Durkin Bryan T
gifted
-
-
-1,367
-
2023-01-18
SHEPARD WILLIAM R
bought
218,906
175
1,243
-
2023-01-18
SHEPARD WILLIAM R
bought
9,650
175
54.839
-
2022-12-31
DUFFY TERRENCE A
sold (taxes)
-3,452,490
168
-20,531
chairman and ceo
2022-12-28
SHEPARD WILLIAM R
bought
48,645
168
289
-
2022-12-28
SHEPARD WILLIAM R
bought
2,144
168
12.757
-
2022-12-15
Tully Sean
acquired
18,936
155
122
sr md global hd rates & otc
2022-12-02
Tierney Robert J JR
bought
264,825
176
1,500
-
2022-11-04
SHEPARD WILLIAM R
bought
8,269,640
170
48,645
-
2022-09-27
SHEPARD WILLIAM R
acquired
2,132
180
11.788
-

1–10 of 50

Terrence A. Duffy
3480
CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois.

CME Income Statement

2022-12-31
CONSOLIDATED STATEMENTS OF INCOME - USD ($)
shares in Thousands, $ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Revenues   
Total Revenues$ 5,019.4$ 4,689.7$ 4,883.6
Expenses   
Compensation and benefits753.1837.0856.5
Technology188.6192.6198.5
Professional fees and outside services137.4151.7191.3
Amortization of purchased intangibles227.7237.6311.2
Depreciation and amortization134.9147.8153.2
Licensing and other fee agreements320.0236.9244.9
Other241.8240.9290.6
Total Expenses2,003.52,044.52,246.2
Operating Income3,015.92,645.22,637.4
Non-Operating Income (Expense)   
Investment income2,198.4306.9182.7
Interest and other borrowing costs(162.7)(166.9)(166.2)
Equity in net earnings (losses) of unconsolidated subsidiaries301.1245.8190.6
Other income (expense)(1,862.4)342.6(122.4)
Total Non-Operating474.4728.484.7
Income before Income Taxes3,490.33,373.62,722.1
Income tax provision799.3736.7615.7
Net income2,691.02,636.92,106.4
Net Income (Loss) Attributable to Noncontrolling Interest0.00.51.2
Net income attributable to CME Group2,691.02,636.42,105.2
Net Income Attributable to Common Shareholders of CME Group$ 2,657.2$ 2,617.1$ 2,105.2
Earnings per Common Share Attributable to CME Group:   
Basic$ 7.41$ 7.30$ 5.88
Diluted$ 7.40$ 7.29$ 5.87
Weighted Average Number of Common Shares:   
Basic358,713358,340357,764
Diluted359,181358,929358,524
Clearing and Transaction Fees [Member]   
Revenues   
Total Revenues$ 4,142.7$ 3,765.1$ 3,897.4
MarketData [Member]   
Revenues   
Total Revenues610.9576.9545.4
OtherRevenue [Member]   
Revenues   
Total Revenues$ 265.8$ 347.7$ 440.8

CME Balance Sheet

2022-12-31
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Assets  
Cash and cash equivalents$ 2,720.1$ 2,834.9
Marketable securities96.0115.0
Accounts receivable, net of allowance483.2434.5
Other current assets529.8427.8
Performance bonds and guaranty fund contributions135,249.2157,949.6
Total current assets139,078.3161,761.8
Property, net of accumulated depreciation and amortization455.5505.3
Intangible assets-trading products[1]17,175.317,175.3
Intangible assets—other, net3,269.73,532.0
Goodwill10,482.510,528.0
Other assets3,714.43,277.9
Total Assets174,175.7196,780.3
Liabilities and Shareholders' Equity  
Accounts payable121.448.8
Short-term debt16.0749.4
Other current liabilities2,300.91,650.6
Performance bonds and guaranty fund contributions135,249.2157,949.6
Total current liabilities137,687.5160,398.4
Long-term debt3,422.42,695.7
Deferred Income Tax Liabilities, Net5,361.15,390.4
Other liabilities826.0896.5
Total Liabilities147,297.0169,381.0
Shareholders' Equity:  
Preferred stock, $0.01 par value, 10,000 shares authorized, none issued or outstanding0.00.0
Additional paid-in capital22,261.622,190.3
Retained earnings4,746.85,151.9
Accumulated other comprehensive income (loss)(133.3)53.5
Total CME Group Shareholders' Equity26,878.727,399.3
Total Liabilities and Shareholders' Equity174,175.7196,780.3
Class A Common Stock (Shares) [Member]  
Shareholders' Equity:  
Common stock3.63.6
Class B Common Stock (Shares) [Member]  
Shareholders' Equity:  
Common stock$ 0.0$ 0.0
[1]Trading products represent futures and options products acquired in our business combinations with CBOT Holdings, Inc., NYMEX Holdings, Inc. and The Board of Trade of Kansas City, Missouri, Inc. Clearing and transaction fees are generated through the trading of these products. These trading products, most of which have traded for decades, require authorization from the CFTC. Product authorizations from the CFTC have no term limits.(2)The activity from deconsolidation includes intangible assets as part of the contribution of the net assets of the optimization business to OSTTRA.